Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43153

CCHCR1 Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

CCHCR1 Knockout hTERT-RPE1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in which the centrosomal and ciliary protein CCHCR1 has been disrupted. Derived from hTERT-immortalized retinal pigment epithelial cells, this model enables investigation of CCHCR1??s role in cell cycle regulation, NF-??B signaling, and ciliogenesis. CCHCR1 functions downstream of TNF-?? and IL-17, interacting with pericentrin and influencing cyclin/CDK expression. This knockout system validates CCHCR1??s contribution to psoriasis pathogenesis and provides a tool for centrosome biology, epithelial homeostasis, and drug sensitivity studies with NF-??B inhibitors.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    CCHCR1

    Gene Identifier

    NCBI Gene ID 54535

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CCHCR1 Knockout hTERT-RPE1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population in which the CCHCR1 gene has been disrupted. This product offers a heterogeneous loss-of-function model suitable for bulk functional analyses, enabling researchers to interrogate CCHCR1-dependent mechanisms without clonal selection artifacts. The polyclonal format captures a range of editing events, providing a robust system for studying gene function in a population context.

The host cell line, hTERT-RPE1, is a non-transformed, hTERT-immortalized human retinal pigment epithelial cell line. These cells maintain key features of primary RPE, including polarized epithelial morphology, primary cilia formation, phagocytic activity, and roles in nutrient transport and blood-retina barrier integrity. Widely employed in RPE biology, epithelial polarity, and ciliogenesis research, hTERT-RPE1 cells provide a physiologically relevant background for CCHCR1 knockout studies.

CCHCR1 encodes a coiled-coil alpha-helical rod protein that localizes to centrosomes and cilia, where it regulates cell cycle progression, cytoskeletal organization, and transcription. Mechanistically, CCHCR1 is activated by upstream regulators such as TNF-?? and IL-17, and it interacts with pericentrin, NF-??B subunits, and IFT88. Downstream of these signals, CCHCR1 modulates expression of cyclins, CDKs, and NF-??B target genes. Through these interactions, CCHCR1 mediates signaling downstream of TNFR and IL17R, influencing the NF-??B pathway and cell cycle control. Disruption of CCHCR1 alters centrosomal function, leading to aberrant proliferation and cytokine responses, as summarized: CCHCR1 localizes to centrosomes and cilia, modulating cell cycle progression and NF-??B signaling; its knockout disrupts centrosomal function and contributes to psoriasis pathogenesis.

In hTERT-RPE1 cells, CCHCR1 knockout holds particular significance for centrosome and cilia biology, given the cell line??s ciliogenic capacity and epithelial architecture. This model permits examination of ciliary assembly, basal body integrity, and the interplay between centrosomal proteins and inflammatory signaling. The RPE context further allows dissection of how CCHCR1 loss impacts epithelial homeostasis and responses to cytokines, with direct relevance to psoriasis and related inflammatory disorders.

This polyclonal knockout cell population supports diverse research applications in psoriasis, centrosome biology, ciliopathy studies, epithelial cell cycle regulation, and inflammatory signaling. Representative assays include Western blotting, immunofluorescence for centrosome/cilia markers (e.g., pericentrin, acetylated tubulin), RT-qPCR, cell cycle flow cytometry, migration/invasion assays, and drug sensitivity studies with NF-??B inhibitors. RNA-seq analysis can further define transcriptional changes upon CCHCR1 disruption. For additional information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)